Trust and Transparency in Medical Device Regulation

The authors discuss the FDA’s decision to end its controversial “alternative summary reporting” program for medical device adverse events, which had allowed manufacturers to report safety problems outside public view, arguing that all adverse event reports should be publicly accessible to maintain trust in device regulation.